New Biosimilar Approvals for Myeloid Growth Factors and Anemia.
Publication
, Conference
Lyman, GH
Published in: J Natl Compr Canc Netw
May 1, 2019
Biosimilars are here to stay, but whether they will enjoy widespread uptake remains to be seen. The FDA sets a high bar for approval of biosimilar products, yet many clinicians remain skeptical about the efficacy and safety of these agents. Favorable experience with >30 biosimilars in Europe provides some reassurance that these agents are safe and effective and can be substituted for the reference product.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
May 1, 2019
Volume
17
Issue
5.5
Start / End Page
622 / 624
Location
United States
Related Subject Headings
- United States
- Oncology & Carcinogenesis
- Humans
- Drug Approval
- Disease Management
- Colony-Stimulating Factors
- Biosimilar Pharmaceuticals
- Anemia
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Lyman, G. H. (2019). New Biosimilar Approvals for Myeloid Growth Factors and Anemia. In J Natl Compr Canc Netw (Vol. 17, pp. 622–624). United States. https://doi.org/10.6004/jnccn.2019.5016
Lyman, Gary H. “New Biosimilar Approvals for Myeloid Growth Factors and Anemia.” In J Natl Compr Canc Netw, 17:622–24, 2019. https://doi.org/10.6004/jnccn.2019.5016.
Lyman GH. New Biosimilar Approvals for Myeloid Growth Factors and Anemia. In: J Natl Compr Canc Netw. 2019. p. 622–4.
Lyman, Gary H. “New Biosimilar Approvals for Myeloid Growth Factors and Anemia.” J Natl Compr Canc Netw, vol. 17, no. 5.5, 2019, pp. 622–24. Pubmed, doi:10.6004/jnccn.2019.5016.
Lyman GH. New Biosimilar Approvals for Myeloid Growth Factors and Anemia. J Natl Compr Canc Netw. 2019. p. 622–624.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
May 1, 2019
Volume
17
Issue
5.5
Start / End Page
622 / 624
Location
United States
Related Subject Headings
- United States
- Oncology & Carcinogenesis
- Humans
- Drug Approval
- Disease Management
- Colony-Stimulating Factors
- Biosimilar Pharmaceuticals
- Anemia
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis